IDEXX Laboratories, Inc. vs Merck & Company, Inc. — Stock Comparison

IDXX
IDEXX Laboratories, Inc.
$567.46
▲ 1.19%
vs
MRK
Merck & Company, Inc.
$112.16
▲ 2.73%
Q·Score Winner
IDEXX Laboratories, Inc.
IDXX7.5/10vs 6.7/10

Q·Score Breakdown

7.5
Bullish
Overall
6.7
Neutral
9
Quality
6.2
7
Health
7
7.9
Growth
6.2
6.6
Valuation
7.2
6.4
Sentiment
7.1
IDXX

High-quality business with 66% return on equity and 25% profit margins.

MRK

Forward P/E of 11.5× is low relative to sector peers.

Analyst Consensus

BUY
Target $724.50 (+27.7%)
14 analysts
BUY
Target $129.74 (+15.7%)
27 analysts

Fundamentals

IDXX
MRK
43.3×
Trailing P/E
31.5×
34.6×
Forward P/E
11.5×
24.6%
Profit Margin
13.6%
61.8%
Gross Margin
76.6%
66.2%
ROE
14.3%
Revenue Growth
4.9%
17.9%
Earnings Growth
1.72
Beta
0.28
Price / Book
$45.2B
Market Cap
$277.0B
$465 – $770
52-Week Range
$73 – $125

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →